Skip to main content
Clinical Trials/KCT0006531
KCT0006531
Completed
未知

A 8 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Echinacea extract on promotion of immunity enhancement

Wonkwang University. Iksan Korean Medicine Hospital0 sites80 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Wonkwang University. Iksan Korean Medicine Hospital
Enrollment
80
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 26, 2021
Last Updated
3 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Wonkwang University. Iksan Korean Medicine Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\) Healthy male and female volunteers between 19 and 70 years old
  • 2\) Volunteers who have received specific experimental illustration and agreed to participate in the study and provided a written content by him/herself

Exclusion Criteria

  • 1\) Those with BMI under 18\.5 kg/m2 or over 35 kg/m2
  • 3\) Those who have consumed medicine or health supplements related to immune function within 1 month before screening
  • 4\) Those who have been treated with antipsychotics within 3 months before screening
  • 5\) Those with or suspected to have alcoholism or substance abuse
  • 6\) Those who participated in other researches within 3 months before screening
  • 7\) Those with these results in diagnostic medical examination
  • ? AST(Aspartate aminotransferase), ALT(Alanine Transaminase) \> three times the normal limit
  • ? Serum Creatinine \> 2\.0 mg/dL
  • 8\) Those who are pregnant or breastfeeding during this study
  • 9\) Those who did not accept implementation of the appropriate contraception method among urban elligible women

Outcomes

Primary Outcomes

Not specified

Similar Trials